F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview and record review, the facility failed to provide one of four sampled residents
(Resident 1) medication as ordered by his physician when Resident 1 did not receive Refresh Liquigel
Ophthalmic Gel 1 % (a thick, gel-like eye drop solution, often called artificial tears) in both eyes at bedtime
for dry eyes.This deficient practice resulted in Resident 1 not receiving Refresh Liquigel Ophthalmic Gel 1
% as ordered and had the potential for Resident 1 to experience dry eyes.Findings:During a review of
Resident 1's admission Record (Face Sheet), the Face Sheet indicated Resident 1 was admitted to the
facility on [DATE] with diagnoses including paraplegia (loss of movement and/or sensation, to some degree,
of the legs).During a review of Resident 1's Minimum Data Set ([MDS] a resident assessment tool) dated
12/4/2025, the MDS indicated Resident 1's cognition (ability to think and reason) was intact required
substantial/ maximal assistance (helper does less than half the effort) from staff to complete his activities of
daily living ([ADLs] activities such as bathing, dressing and toileting a person performs daily).During a
review of Resident 1's Order Summary Report (Physician Order's) dated 12/18/2025, Resident 1 was to
receive Refresh Liquigel Ophthalmic Gel 1 % one application in both eyes at bedtime for dry eyes, ordered
on 12/18/2025. During an interview on 12/30/2025 at 10:56 a.m., Resident 1 stated he has not been
receiving the eye drops at night that were ordered by his physician.During a concurrent observation and
interview on 12/30/2025 at 11:57 a.m. with Licensed Vocational Nurse (LVN) 1, of the East 2 Station
medication cart, LVN 1 stated there were no Refresh eye drops in the medication cart for Resident 1 and
would need to follow up with the supervisor.During a concurrent observation and interview on 12/30/2025 at
12:21 p.m. and subsequent interview on 12/30/2025 at 2:36 p.m., with Registered Nurse (RN) 1, of the
facility's House Supply closet (a locked storage area where a collection of over-the-counter medications
[any non-prescription medicine] are kept in the facility) RN 1 stated there was no Refresh drops in the
House Supply closet. RN 1 stated she could not find any pharmacy delivery receipts of the Refresh drops
for Resident 1 indicating the Refresh drops were delivered to the facility. RN 1 stated there should have
been a follow up regarding Resident 1's Refresh eye drops to see why it was not delivered to facility. RN 1
stated if Resident 1 does not receive the prescribed eye drops then Resident 1's eye dryness will remain
untreated.During an interview on 12/30/2025 at 1:07 p.m., the Pharmacist confirmed Resident 1's order for
the Refresh eye drops was processed today (12/30/2025). The Pharmacist stated if the medication is an
over-the-counter medication, the Pharmacy will not provide it, unless it was specifically requested by the
facility. The Pharmacist stated there was no documentation that the facility called regarding the Refresh eye
drops.During a review of the facility's policy and procedure (P&P) titled Pharmacy Services, dated 4/2019,
the P&P indicated residents have sufficient supply of their prescribed medications and receive medications
(routine, emergency or as needed) in a timely manner. The P&P indicated nursing staff should
communicate prescriber orders to the
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
056164
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056164
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Pacific Palms Healthcare
1020 Termino Avenue
Long Beach, CA 90804
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
pharmacy and are responsible for contacting the pharmacy if a resident's medication is not available for
administration.
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056164
If continuation sheet
Page 2 of 2